# ING PHARMA LLC: Form D filing

ING PHARMA LLC, a pharmaceuticals company in Indianapolis, IN, filed a Form D with the SEC in 2011. The latest, on January 21, 2011, reports $615,500 sold of a $615,500 offering to 25 investors.

Find out what ING PHARMA LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20ING%20PHARMA%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=ING%20PHARMA%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fing-pharma-llc-1510840)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20ING%20PHARMA%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=ING%20PHARMA%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fing-pharma-llc-1510840)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Indiana](https://specstream.ai/data/form-d/state/indiana): 436 rows, by operating companies, filed since November 1, 2024, $21.80, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/indiana
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 8333 Naab Road, Suite 250, Indianapolis, IN, 46260
- Phone: (317) 396-1374
- Industry: Pharmaceuticals
- Entity type: Limited Liability Company
- Incorporated in: Indiana
- Year incorporated: 2010
- Revenue range: No Revenues
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1510840

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 21, 2011 | New notice | $615,500 | $615,500 | $0 | 25 | Jan 30, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1510840/000114420411003364/0001144204-11-003364-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Eric Potts, M.D. | Executive Officer |  |

[Every Form D from the week of Jan 17, 2011](https://specstream.ai/data/form-d/week/2011-01-17) · [All recent filings in Indiana](https://specstream.ai/data/form-d/state/indiana) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what ING PHARMA LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).